Cargando…

On the way to developing AAV-based vaccines as novel tools for cancer immunotherapy

Detalles Bibliográficos
Autor principal:	Hacker, Ulrich T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982205/ https://www.ncbi.nlm.nih.gov/pubmed/36874246 http://dx.doi.org/10.1016/j.omtm.2023.02.009

Ejemplares similares

The hunt for novel AAV capsids with improved cardiac tropism
por: Miguel-dos-Santos, Rodrigo, et al.
Publicado: (2023)

Immunotherapy - a potential new way forward in the treatment of sepsis
por: Payen, Didier, et al.
Publicado: (2013)

It’s a long way to the top (if you want to personalize immunotherapy)
por: Haebe, Sarah, et al.
Publicado: (2017)

Novel vaccines for allergen-specific immunotherapy
por: Akinfenwa, Oluwatoyin, et al.
Publicado: (2021)

Top-of-the-art cytometry as a novel tool to aid in lung cancer immunotherapy
por: Mondelo-Macía, Patricia, et al.
Publicado: (2023)

AAV-vectored base editor trans-splicing delivers dystrophin repair
por: Li, Zhen, et al.
Publicado: (2023)

PROTAC vaccine: A new way to live attenuated vaccines
por: Li, Zhen, et al.
Publicado: (2022)

Adult vaccination in India: status and the way forward
por: Lahariya, Chandrakant, et al.
Publicado: (2019)

Tarlatamab: the promising immunotherapy on its way from the lab to the clinic
por: Tang, Daolin, et al.
Publicado: (2023)

HIV self-testing: finding its way in the prevention tool box
por: Ortblad, Katrina F., et al.
Publicado: (2020)

Development of an Allergy Immunotherapy Leads to a New Type of Hepatitis B Vaccine
por: Gerlich, Wolfram H., et al.
Publicado: (2016)

Synopsis of the 6(th )Walker's Cay Colloquium on Cancer Vaccines and Immunotherapy
por: Kast, W Martin, et al.
Publicado: (2004)

BCG vaccine and COVID-19: implications for infection prophylaxis and cancer immunotherapy
por: Koti, Madhuri, et al.
Publicado: (2020)

Recent developments of acupuncture in Australia and the way forward
por: Xue, Charlie Changli, et al.
Publicado: (2009)

New ways and new hopes for IGR development
por: Jindra, Marek
Publicado: (2021)

The future of cancer immunotherapy: DNA vaccines leading the way
por: Pandya, Aanshi, et al.
Publicado: (2023)

Oracle or false prophet? Can we predict AAV efficacy based on preexisting antibody titers?
por: Anguela, Xavier M., et al.
Publicado: (2019)

Repurposing infectious disease vaccines for intratumoral immunotherapy
por: Melero, Ignacio, et al.
Publicado: (2020)

Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development
por: Cohen, Samuel A., et al.
Publicado: (2020)

HSP70-based anti-cancer immunotherapy
por: Guzhova, Irina V., et al.
Publicado: (2016)

AAV vector production: Troublesome host innate responses in another setting
por: Wright, J. Fraser
Publicado: (2023)

Engineered AAV vectors for improved central nervous system gene delivery
por: A Kotterman, Melissa, et al.
Publicado: (2015)

Genetic instability and increased mutational load: which diagnostic tool best direct patients with cancer to immunotherapy?
por: Palmieri, Giuseppe, et al.
Publicado: (2017)

Biomonitoring as an Underused Exposure Assessment Tool in Occupational Safety and Health Context—Challenges and Way Forward
por: Viegas, Susana, et al.
Publicado: (2020)

Vaccine safety concerns: Should we be changing the way we support immunization?
por: MacDonald, Noni E, et al.
Publicado: (2020)

Launching COVID-19 vaccination in Saudi Arabia: Lessons learned, and the way forward
por: Assiri, Abdullah, et al.
Publicado: (2021)

Breaching the blood-brain barrier: AAV triggers dose-dependent toxicity in the brain
por: Stone, Daniel, et al.
Publicado: (2023)

Goody two plasmids: An optimized transient transfection system for AAV vector production
por: Moreno Velasquez, Sergio David, et al.
Publicado: (2023)

Determination of AAV properties by single amino acids: Go(o)d is in the details
por: Maiakovska, Olena, et al.
Publicado: (2022)

Cancer immunotherapy trials: leading a paradigm shift in drug development
por: Emens, Leisha A., et al.
Publicado: (2016)

Two roads for oncolytic immunotherapy development
por: Kaufman, Howard L., et al.
Publicado: (2019)

Cancer immunotherapy by immunosuppression
por: Prehn, Richmond T, et al.
Publicado: (2010)

Immunotherapy for penile cancer
por: Buonerba, Carlo, et al.
Publicado: (2017)

Tackling barriers to scale up human papillomavirus vaccination in China: progress and the way forward
por: Zhao, Xue-Lian, et al.
Publicado: (2023)

Novel statistical approach offers new way to investigate the uses of acupuncture points
por: Birch, S., et al.
Publicado: (2020)

Ethnicity and prostate cancer: the way to solve the screening problem?
por: Bokhorst, Leonard P., et al.
Publicado: (2015)

“Splice” a way towards neuroendocrine prostate cancer
por: Zhang, Dingxiao, et al.
Publicado: (2018)

Targetless T cells in cancer immunotherapy
por: thor Straten, Per, et al.
Publicado: (2016)

Circulating neurofilaments to track dorsal root ganglion toxicity risks with AAV-mediated gene therapy
por: Farrar, Michelle A., et al.
Publicado: (2022)

No Easy Way Out (Or in)
por: De Weer, Paul
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_p7cvfletf6eacd7ng9unr90g9c